Police say multiple businesses have reported receiving counterfeit $100 bills after individuals attempted to sue the fake ...

The cashier called the manager to tell them, who marked it with a counterfeit pen and found it wasn’t genuine money. “To the left of Andrew Jackson’s smirking face was printed ‘This note ...

Using the smallest needle size for pen insulin injectors may be worth considering. If you find using a pen medication injector to be painful, you may be able to eliminate this problem by switching to ...

CINCINNATI (WKRC) - The surge in popularity of weight loss drugs like Ozempic and Trulicity has led to a rise in counterfeit versions ... it’s upwards of 40, 50 pens or even more at times ...

The dangers to health are real. Novo Nordisk reported one counterfeit pen contained the diabetes medicine insulin. The user was hospitalized after administering the counterfeit pen. Authorities ...

The proliferating circulation of counterfeit goods has been a top concern for luxury and mass-market market brands alike for decades, and as the second-hand market continues to flourish ...

The introduction of smart insulin pens, which represent a substantial development in the technology currently used to control diabetes, may benefit patients who are reliant on insulin by enhancing ...

Amazon says it’s working to fix issues with the Kindle Colorsoft, its first color e-reader, following complaints from early buyers that a yellow band of discoloration appears on the bottom of ...

VITAMIN C – The National Bureau of Investigation (NBI) and the Food and Drug Administration (FDA) raided a counterfeit Vitamin C syrup facility in Pampanga. Authorities from the NBI and FDA recently ...

Depots and Petroleum Products Marketers Association of Nigeria (DAPPMAN) an umbrella body of depot owners and major fuel marketers, has disputed the claim by the Dangote Refinery Management that ...

Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.